SEC Contract Filing

Filing Date: 2021-11-08

Document Content:
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>7
<FILENAME>tm2132016d1_ex10-3.htm
<DESCRIPTION>EXHIBIT 10.3
<TEXT>
<HTML>
<HEAD>
 <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&#8239;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.3</B></P>

<P STYLE="margin: 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATION RIGHTS AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS REGISTRATION RIGHTS AGREEMENT
(this &ldquo;<B><I>Agreement</I></B>&rdquo;), dated as of November&#8239;3, 2021, is made and entered into by and among Digital Health
Acquisition Corp., a Delaware corporation (the &ldquo;<B><I>Company</I></B>&rdquo;) and Digital Health Sponsor, LLC, a Delaware limited
liability company (the &ldquo;<B><I>Sponsor</I></B>&rdquo;) (and together with any other parties listed on the signature pages&#8239;hereto
and any person or entity who hereafter becomes a party to this Agreement pursuant to <U>Section&#8239;&lrm;5.2 </U>of this Agreement, being
referred to herein as a &ldquo;<B><I>Holder</I></B>&rdquo; and collectively as the &ldquo;<B><I>Holders</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RECITALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Company
and the Sponsor have entered into that certain Securities Subscription Agreement, dated as of June&#8239;7, 2021, pursuant to which the
Sponsor purchased an aggregate of 3,044,500 shares (the &ldquo;<B><I>Sponsor Shares</I></B>&rdquo;) of the Company&rsquo;s common stock
(the <B>&ldquo;<I>Common Stock</I></B>&rdquo;), par value $0.0001 per share, of which, 971,250 shares were forfeited on October&#8239;26,
2021 and up to 270,424 shares will be forfeited to the Company for no consideration depending on the extent to which the underwriters
of the Company&rsquo;s initial public offering exercise their over-allotment option;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Company
and certain other initial stockholders (the &ldquo;<B><I>Other Stockholders</I></B>&rdquo;) entered into separate Securities Subscription
Agreements, each dated June&#8239;7, 2021, pursuant to which the Company issued to the Other Stockholders an aggregate of 1,268,000 shares
of Common Stock of the Company (the &ldquo;<B><I>Other Stockholder Shares</I></B>&rdquo; and together with the Sponsor Shares, the &ldquo;<B><I>Founder
Shares</I></B>&rdquo;), of which, 466,250 shares were forfeited on October&#8239;26, 2021 and up to 104,576 shares will be forfeited to
the Company for no consideration depending on the extent to which the underwriters of the Company&rsquo;s initial public offering exercise
their over-allotment option;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, on November&#8239;3,
2021, the Company and the Sponsor entered into that certain Placement Unit Subscription Agreement (the &ldquo;<B><I>Sponsor Unit Subscription
Agreement</I></B>&rdquo;), pursuant to which the Sponsor agreed to purchase 509,000 units (or up to 557,000 units to the extent the over-allotment
option in connection with the Company&rsquo;s initial public offering is exercised in full) (the &ldquo;<B><I>Sponsor Private Placement
Units</I></B>&rdquo;), each unit consisting of one share of Common Stock and one warrant to purchase one share of Common Stock, in a private
placement transaction occurring simultaneously with the closing of the Company&rsquo;s initial public offering; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Company
and the Holders desire to enter into this Agreement, pursuant to which the Company shall grant the Holders certain registration rights
with respect to certain securities of the Company, as set forth in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOW</B>, <B>THEREFORE</B>,
in consideration of the representations, covenants and agreements contained herein, and certain other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&#8239;I</B></FONT><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DEFINITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Definitions</U>.
The terms defined in this <I><U>Article&#8239;I</U></I> shall, for all purposes of this Agreement, have the respective meanings set forth
below:<